Cronos Group Files Form 12b-25
November 09, 2021 07:30 ET
|
Cronos Group Inc.
TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has filed a Form 12b-25 with the U.S. Securities and...
Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire
October 29, 2021 07:30 ET
|
Cronos Group Inc.
Arye Weigensberg Named Interim Head of Research and Development Search to Identify Permanent Successor Well Underway TORONTO, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON)...
Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy
October 20, 2021 06:00 ET
|
Cronos Group Inc.
Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using fermentation and proprietary methods to produce CBG without using the cannabis plantThe SPINACH...
Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids
August 23, 2021 07:30 ET
|
Cronos Group Inc.
TORONTO and BOSTON, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks (“Ginkgo”), which...
Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference
August 09, 2021 17:00 ET
|
Cronos Group Inc.
TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike...
Cronos Group Appoints Bob Madore as Chief Financial Officer
August 06, 2021 07:33 ET
|
Cronos Group Inc.
TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced the appointment...
Cronos Group Reports 2021 Second Quarter Results
August 06, 2021 07:30 ET
|
Cronos Group Inc.
Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis company Spinach™ launched new...
Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies
July 29, 2021 07:00 ET
|
Cronos Group Inc.
SOURZ by Spinach™ gummies offer adult consumers a bold and juicy new cannabis edible featuring great tasting dual flavors and dual colors TORONTO, July 29, 2021 (GLOBE NEWSWIRE) -- Cronos Group...
Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021
July 23, 2021 08:00 ET
|
Cronos Group Inc.
TORONTO, July 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Second Quarter Earnings Conference Call on Friday, August...
Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders
June 25, 2021 16:05 ET
|
Cronos Group Inc.
TORONTO, June 25, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that at its Annual Meeting of Shareholders held earlier today (the...